Mike is Vice President, Cardiovascular and Metabolic Diseases. He is responsible for the strategic direction and performance of the Cardiovascular business unit
Prior to his time at AstraZeneca, Mike was General Manager for Roche Korea, responsible for all commercial and administrative functions. Mike has also served as General Manager of Roche Indonesia and as a Global Business leader overseeing hematology/oncology and inflammation brands based in Basel, Switzerland.
Mike began his career in Canada and held a number of sales and marketing roles at Servier Canada, Novartis, and Hoffman-La Roche across several different therapeutic areas, including cardiovascular, endocrinology, and oncology.
- Bachelor of Science, Bishop’s University, Quebec
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.